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Abstract
Background: Protein A, protein G and protein L are three well-defined immunoglobulin (Ig)-binding
proteins (IBPs), which show affinity for specific sites on Ig of mammalian hosts. Although the precise
functions of these molecules are not fully understood, it is thought that they play an important role in
pathogenicity of bacteria. The single domains of protein A, protein G and protein L were all demonstrated
to have function to bind to Ig. Whether combinations of Ig-binding domains of various IBPs could exhibit
useful novel binding is interesting.
Results: We used a combinatorial phage library which displayed randomly-rearranged various-peptide-
linked molecules of D and A domains of protein A, designated PA(D) and PA(A) respectively, B2 domain
of protein G (PG) and B3 domain of protein L (PL) for affinity selection with human IgG (hIgG), human IgM
(hIgM), human IgA (hIgA) and recombinant hIgG1-Fc as bait respectively. Two kinds of novel combinatorial
molecules with characteristic structure of PA(A)-PG and PA(A)-PL were obtained in hIgG (hIgG1-Fc) and
hIgM (hIgA) post-selection populations respectively. In addition, the linking peptides among all PA(A)-PG
and PA(A)-PL structures was strongly selected, and showed interestingly divergent and convergent
distribution. The phage binding assays and competitive inhibition experiments demonstrated that PA(A)-
PG and PA(A)-PL combinations possess comparable binding advantages with hIgG/hIgG1-Fc and hIgM/hIgA
respectively.
Conclusion: In this work, a combinatorial phage library displaying Ig-binding domains of protein A,
protein G, or protein L joined by various random linking peptides was used to conducted evolutional
selection in vitro with four kinds of Ig molecules. Two kinds of novel combinations of Ig-binding domains,
PA(A)-PG and PA(A)-PL, were obtained, and demonstrate the novel Ig binding properties.
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Background
Bacterial immunoglobulin (Ig)-binding proteins (IBPs)
are cell-anchored which can bind to specific sites on Ig of
the host and mediate pathogenicity in host [1]. Protein A
of Staphylococcus aureus (SpA), protein G of group C and G
streptococci (SpG), and protein L of Finegoldia magna for-
merly  Peptostreptococcus magnus are three well-defined
IBPs. Although the precise functions of these molecules
are not fully understood, it is thought that they play an
important role in pathogenicity of bacteria. SpA com-
prises 524 amino acid residues with a molecular weight of
57 KD. The extracellular part of SpA contains a tandem
repeat of five highly homologous IgG-binding domains
designated (from the N terminus) E, D, A, B and C, each
of which contains about 58 amino acid residues. The over-
all structures of these domains are all up-down three α-
helixes and all five domains of SpA show Ig-binding abil-
ities [2-4]. SpG (about 63 KD) is composed of 594 amino
acid residues, containing 3 highly homologous Ig-binding
domains identified as B1, B2 and B3 [5]. Each domain of
SpG consists of two pairs of antiparallel β-sheets con-
nected by a single α-helix [6,7]. Protein L is a 95 KD pro-
tein and contains 719 amino acid residues, with the Ig-
binding activity located in five homologous repeats, Bl-
B5, each comprising 72–76 amino acid residues. The fold
of the Ig-binding domains of protein L is similar to that of
the domains of SpG [8,9].
Both SpA and SpG show high affinity for the interface
between the second constant region of heavy chain (CH2)
and CH3 domains (CH2γ–CH3γ) of IgG crystallizable
fragment (Fc) [10]. In addition, SpA can bind to fragment
of antigen binding (Fab) of a subset of Igs with variable
region of heavy chains belonging to human VHIII family,
so SpA is capable of binding to other types of Ig molecules
besides IgG [11,12]. In contrast to SpA, SpG binds to Fab
with the first constant region of Ig γ chain (CH1γ), so SpG
can bind only to IgG [13]. Protein L has been shown to
bind to κ light chains of Ig, so it can bind to all types of Ig
molecules that contain a kappa light chain [14,15].
Some hybrid IBPs, like protein AG, Protein LG and Pro-
tein LA had been constructed [16-18], and were shown to
sustain Ig-binding property of parental proteins and
broaden Ig-binding spectra. Protein AG was shown to pos-
sess higher affinity for IgG than SpA or SpG. In addition
to the enhanced affinity for IgG and IgG-Fc, protein LA
showed enhanced affinity for Ig Fab or majority of human
single chain variable antibody fragment (scFv) carrying
the κ light-chain variable domain or expressing the VHIII
determinant. It suggested complementary effect of Ig-
binding in these hybrid IBPs.
The single domains of SpA, SpG and protein L were all
demonstrated to have function to bind to Ig [17,19-21].
Whether combinations of Ig-binding domains of various
IBPs could exhibit useful novel binding remain interest-
ing. In this study, we used the single Ig-binding domains
of SpA, SpG and protein L as basic functional units to con-
struct a combinatorial phage library displaying randomly-
rearranged molecules joined by various random linking
peptides, and conducted evolutional selection in vitro
with four kinds of Ig molecules as bait. Two kinds of novel
combinations of Ig-binding domains, PA(A)-PG and
PA(A)-PL, were obtained, and might represent improved
Ig-binding properties.
Results
Distribution of various fragment sizes displayed by phage 
library and post-selection populations
To evaluate the Ig affinity selection efficacy, some markers
including phage library binding capacity, output/input
ratio of phages, distribution of various fragment size etc.
were measured. The library binding capacity and output/
input ratio did not correspond well with the affinity selec-
tion (data not shown). We found the distribution of frag-
ment sizes changed remarkably during the selection (Fig.
1). As figure 2 shows, the proportion of phage clones dis-
playing two domains and three domains in original
library was 22%, then increased dramatically and reached
80%–100% after four rounds of selection with hIgG and
recombinant hIgG1-Fc (Fig. 2A, 2B). In hIgM and hIgA
selection, the proportion of phage clones displaying two
domains and three domains also increased remarkably
from 22% to 98% and 22% to 96% respectively after three
or four rounds of selection (Fig. 2C, 2D). These results
corresponded well with our previous experiment that also
indicated that along with the rounds of selection, the pro-
portion of phage clones displaying large fragments
increased [22], and it might represent effective selection.
Analyses of inserted fragments of the post-selection 
populations
In the fourth post-selection population selected with hIgG
or hIgG1-Fc, twenty phage clones were randomly chosen
for sequencing analysis. It was very interesting that the
twenty sequenced phage clones from hIgG and hIgG1-Fc
selection populations displayed the same combinations,
all containing PA(A)-PG with different linking peptides
(Table 1). Interesting results were also found about the
distribution of random linking peptides. The different
linking peptides showed divergent distribution in hIgG
and hIgG1-Fc fourth post-selection populations. Of six
different linking models, only PA(A)-PG (the second col-
umn in Table 2) existed in both hIgG and hIgG1-Fc post-
selection populations, the other five PA(A)-PG combina-
tions (from the third to seventh columns in Table 2) with
different linking peptides existed in hIgG or hIgG1-Fc
post-selection population.BMC Microbiology 2008, 8:137 http://www.biomedcentral.com/1471-2180/8/137
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Similar to the situation in hIgG or hIgG1-Fc selection, the
displayed molecules in hIgA fourth post-selection popula-
tion showed the same combinations with that in hIgM
third post-selection population, all containing the PA(A)-
PL (Table 1). In the twenty one randomly picked
sequenced clones, twelve displayed PA(A)-PL and nine
displayed PA(A)-PA(A)-PL (Table 1). In contrast with the
results of hIgG and hIgG1-Fc selection populations, the
sequences of linking peptides among PA(A)-PL structures
tended to show convergent distribution. Almost all (4 of
5) combinations with different linking peptides existed in
both hIgA and hIgM selection populations (from the sec-
ond to fifth columns in Table 3), with an exception of
PA(A)9N-PL (the sixth column in Table 3).
The Ig binding properties of the representative phages
Eight representative positive phage clones were chosen
and tested for the Ig binding properties. As figure 3 shows,
number 1 to 5 of phage clones displaying PA(A)-PG as
well as SpA-phage (clone 9) possessed strong binding
activity with hIgG and hIgG1-Fc, but showed little bind-
ing to hIgM or hIgA, though this binding may theoreti-
cally exist through PA(A) domain interacting with VHIII
region. It was very interesting that clone 4 and 5, which
were from hIgG post-selection population, showed even
stronger binding to hIgG than SpA-phage as well as clone
1, 2 and 3 which were found in hIgG1-Fc post-selection
population (Fig. 3A). Clone 1, 2 and 3 showed even
stronger binding to hIgG1-Fc than SpA-phage as well as
clone 4 and 5 which were found in hIgG post-selection
population (Fig. 3B). This binding priority suggested that
the linking peptides could affect the Ig-binding properties.
Compared with SpA-phage and 2L-phage (clone 10),
clone 6, 7 and 8 displaying PA(A)-PL from hIgM or hIgA
post-selection populations showed remarkable enhanced
binding to hIgM or hIgA (Fig. 3C, 3D) and weak binding
activity with hIgG and hIgG1-Fc (Fig. 3A, 3B). As SpA-
phage, clone 1 to 5 phages showed some weak binding to
hIgM or hIgA. 2L-phage bound to hIgG, hIgM or hIgA
obviously, but showed no binding to hIgG1-Fc.
The Ig binding properties of the novel combinatorial 
molecules
To test the binding properties of selected combinatorial
molecules, these molecules were expressed as fusion pro-
teins with thioredoxin using expression vector pET32a(+)
and performed Western Blot. All the PA-PG combinations
as well as SpA and SpG showed strong binding to hIgG
(Fig. 4A) and hIgG1-Fc (Fig. 4B), and weak binding to
hIgM (Fig. 4C) and hIgA (Fig. 4D). Inconsistent with
phage binding assays, the expressed PA-PG combinations
did not show any binding advantage to hIgG (Fig. 4A) and
hIgG1-Fc (Fig. 4B) compared with SpA and SpG. In con-
trast to PA-PG, the expressed PA-PL combinations showed
much stronger binding to hIgM (Fig. 4C) and hIgA (Fig.
Detection of inserted fragments of phage clones in each round of hIgG selection library by PCR Figure 1
Detection of inserted fragments of phage clones in each round of hIgG selection library by PCR. PCR products 
were analyzed by electrophoresis in 1.2% agarose gel and detected by staining with ethidium bromide. No. 1 to 22: randomly 
picked phage clones; M: DL2000 Marker; C: positive control (pCANTAB5S vector); B: negative control (blank culture 
medium); I, II, III, IV: the first to the fourth round of selection respectively.BMC Microbiology 2008, 8:137 http://www.biomedcentral.com/1471-2180/8/137
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Proportion of phage clones with different sizes of inserted fragments in 22 phage clones after each round of selection with four  Ig molecules respectively (A-D) Figure 2
Proportion of phage clones with different sizes of inserted fragments in 22 phage clones after each round of 
selection with four Ig molecules respectively (A-D).  : phage clones with no inserted fragment;  : phage clones dis-
playing one domain of combinatorial Ig-binding molecules;  : phage clones displaying two domains of combinatorial Ig-binding 
molecules;  : phage clones displaying three domains of combinatorial Ig-binding molecules.
Table 1: Sequence analyses of inserted fragments on phage clones in the original library and the third or fourth post-selection libraries 
with four Ig molecules
Phage Libraries Composition of single domains of inserted fragment
The original phage library (5*) PG-PL9N; PA(A)-PG-PL6N; PG3N
R-PGR-PA(D)6N; PL3N-PA(D); PG6N-PA(A)3N-PLR
The 4th round of selection with hIgG (10) PA(A)-PG9N(5**);PA(A)-PG(2); PA(A)-PG3N(2); PA(A)6N-PG3N
The 4th round of selection with hIgG1-Fc (10) PA(A)-PG(7); PA(A)6N-PG(2); PA(A)3N-PG-PA(A)
The third round of selection with hIgM (11) PA(A)-PL-PL9N(4); PA(A)6N-PL9N(2); PA(A)-PL3N(3); PA(A)9N-PL3N; PA(A)9N-PL
The 4th round of selection with hIgA (10) PA(A)-PL-PL9N(5); PA(A)6N-PL9N(2); PA(A)-PL3N(2); PA(A)9N-PL3N
*: Number of sequenced phage clones; **: number of phage clones with the same inserted fragment; PA(A) and PA(D): A and D domains of protein 
A; PG: B2 domain of protein G; PL: B3 domain of protein L; 3N, 6N and 9N: the sequence of random linking peptides composed of three, six and 
nine nucleotides; R: reverse sequence of original sequence.BMC Microbiology 2008, 8:137 http://www.biomedcentral.com/1471-2180/8/137
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4D) than 4L and SpA respectively, which was consistent
with phage binding assay.
The PA(A)-PG or PA(A)-PL combinations showed binding 
advantages
To test whether PA(A)-PG or PA(A)-PL combinations pos-
sess some binding advantages, we expressed the fusion
proteins of PA(A)3N-PG-PA(A), PA(A)6N-PG from hIgG1-
Fc post-selection population, PA(A)-PG9N, PA(A)6N-PG3N
from hIgG post-selection population, and PA(A)9N-PL3N
and PA(A)9N-PL from hIgM/hIgA post-selection popula-
tion to perform competitive inhibition experiments. As
figure 5 shows, all four PA(A)-PG combinations inhibited
the binding of PA(A)-PG-phages to hIgG more efficiently
than SpA and SpG alone (Fig. 5A, 5B, 5C, 5D). Further-
more, PA(A)-PG9N and PA(A)6N-PG3N from hIgG post-
selection population showed more efficient inhibition
than SpA, SpG and that both (Fig. 5C, 5D), while all four
PA(A)-PG combinations inhibited the binding of SpA-
phages to hIgG as efficiently as SpA, SpG and that both
(Fig. 5E). Similar results were obtained for inhibition of
PA(A)-PG-phages binding to hIgG1-Fc by competitive
inhibition tests as above (data not shown). Consistent
with phage binding tests (Fig. 3), the competitive inhibi-
tion experiments documented that the PA(A)-PG combi-
nations possess some binding advantages to hIgG or
hIgG1-Fc.
For PA(A)-PL-phages competitive inhibition experiments,
expressed PA(A)-PL combinations inhibited the binding
of PA(A)-PL-phages to hIgM much more efficiently than
4L, SpA alone and that both (Fig. 6A, 6B), while all PA(A)-
PL combinations inhibited the binding of SpA-phage (Fig.
6C) or 2L-phage (Fig. 6D) to hIgM as efficiently as SpA,
SpA and 4L or 4L, 4L and SpA respectively. Similar results
were obtained for inhibition of PA(A)-PL-phages binding
to hIgA by competitive inhibition tests as above (data not
shown). Consistent with phage binding tests (Fig. 3), the
competitive inhibition experiments showed the PA(A)-PL
combinations possess obvious binding advantage to hIgM
or hIgA.
Discussion
Compared with SpA-phage displaying five domains of
SpA, phages displaying PA(A)-PL which was contained in
each sequenced clone as predominant combinations in
hIgM and hIgA post-selection populations exhibited a
remarkable enhanced binding affinity for hIgM and hIgA
(Fig. 3). The prokaryotic expressed PA(A)-PL combina-
tions also showed the same binding properties (Fig. 4C,
4D). Protein L binds primarily to κ light chains of I, III, IV
subtypes of Igs [8], while SpA binds about 22% hIgA and
40% hIgM through interacting with VHIII region [11,23].
The coexistence of single domains of SpA and protein L
could broaden the Ig-binding spectra, and achieve the
binding advantage of PA(A)-PL for hIgM and hIgA. How-
ever, the loss of other possible combinations, like PL-PL,
which should have same chance to be produced in origi-
nal library, and may produce enhanced affinity for κ light
chains due to avidity effect, suggested that PA(A)-PL
should have additional binding advantage. Considering
the binding properties of protein L and SpA and the struc-
ture of Ig-Fab, we speculated that the binding advantage
of PA(A)-PL might be produced through double-site bind-
Table 2: Sequences of random linking peptides in PA(A)-PG structure and their distribution in hIgG and hIgG1-Fc selected libraries
Combinatorial form of single domains PA(A)-PG PA(A)-PG9N PA(A)-PG3N PA(A)6N-PG3N PA(A)6N-PG PA(A)3N-PG-PA(A)
Nucleotide sequence of random linking peptide - AGC TTA CAC CAC ACC TCG ACC CAC TCA CCA
Amino acid sequence of random linking peptide - S L H H T S T H S P
Number of clones Selected with hIgG (10*) 2 5 21 00
Number of clones Selected with hIgG1-Fc (10) 7 0 00 21
*: Number of sequenced phage clones; Underlined and italic parts represent the nucleotide and amino acid sequences of linking peptide followed 
the second domain. 3N, 6N and 9N: the sequence of random linking peptides composed of three, six and nine nucleotides. Single letter 
abbreviations of amino acids: H, His; L, Leu; P, Pro; S, Ser; T, Thr.
Table 3: Sequences of random linking peptides in PA(A)-PL structure and their distribution in hIgM and hIgA selected libraries
Combinatorial form of single domains PA(A)-PL-PL9N PA(A)6N-PL9N PA(A)-PL3N PA(A)9N-PL3N PA(A)9N-PL
Nucleotide sequence of random linking peptide TAC TGG TTG AAA CTA GCT AAC AAC TTG GGT GAG ATG CAC GAC TTT ATT
Amino acid sequence of random linking peptide Y W L K L A N N L G E M H D F I
Number of clones selected with hIgM (11*) 42 3 1 1
Number of clones selected with hIgA (10) 52 2 1 0
*: Number of sequenced phage clones; Underlined and italic parts represent the nucleotide and amino acid sequences of linking peptide followed 
the second domain. 3N, 6N and 9N: the sequence of random linking peptides composed of three, six and nine nucleotides. Single letter 
abbreviations of amino acids: A, Ala; D, Asp; E, Glu; F, Phe; G, Gly; H, His; I, Ile; K, Lys; L, Leu; M, Met; N, Asn; W, Trp; Y, Tyr.BMC Microbiology 2008, 8:137 http://www.biomedcentral.com/1471-2180/8/137
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ing to VHIII and Vκ regions of Fab in hIgM and hIgA. In
Fab fragment of hIgM and hIgA, the conformation of VH-
VL is tightly fixed due to the interchain disulfide bond
between VH and VL regions and non covalent interaction
of VH-VL interface [24]. Moreover, the binding sites of
protein L and SpA on Ig-Fab located on the opposite sur-
face of the antigen binding cleft, and both interactions
produce little steric hindrance to each other [15,25]. These
characteristics are in favor of the double site binding of
PA(A)-PL to VHIII and Vκ regions. This speculation was
clearly supported by results of competitive inhibition
experiments which showed that 4L, SpA alone or that
both couldn't inhibit the binding of PA(A)-PL-phages to
hIgM or hIgA as efficiently as PA(A)-PL combinations
(Fig. 6A, 6B).
It is predictable that PA(A)-PG combinations would be
selected in hIgG and hIgG1-Fc post-selection populations.
Detection of the binding activity of representative phage clones with four Ig molecules respectively by ELISA (A-D) Figure 3
Detection of the binding activity of representative phage clones with four Ig molecules respectively by ELISA 
(A-D). Each of Ig molecules (labeled on top of each graph) was coated on ELISA plates using 0.1 M NaHCO3 (pH 9.6). The 
amplified representative phages (2 × 1011 TU) were added to each well and Ig-bound phages were detected with horseradish 
peroxidase (HRP)-conjugated anti-M13 antibody. The displayed sequence of each representative phages was: 1, PA(A)3N-PG-
PA(A); 2, PA(A)6N-PG; 3, PA(A)-PG; 4, PA(A)-PG9N; 5, PA(A)6N-PG3N; 6, PA(A)9N-PL3N; 7, PA(A)-PL-PL9N; 8, PA(A)9N-PL; 9, 
SpA-phage (positive control); 10, 2L-phage (positive control); 11, pCANTAB5S-phage (negative control). Comparable data 
were obtained in three independent experiments.BMC Microbiology 2008, 8:137 http://www.biomedcentral.com/1471-2180/8/137
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However, it was unexpected that PA(A)-PG was so pre-
dominant while PA(A/D)-PA (A/D) or PG-PG which had
similar binding potential and same chance to be pro-
duced in original library was not selected (Table 2). This
result suggests that PA(A)-PG combinations possess an
advantage over other combinations in binding to Fc
regions. It was supported by the phage binding assay
which showed that the PA(A)-PG-phages selected by hIgG
or hIgG1-Fc exhibited stronger binding to hIgG or hIgG1-
Fc respectively than SpA-phages (Fig. 3A, 3B) and by the
competitive inhibition test which showed that PA(A)-PG
combinations inhibited the binding of PA(A)-PG-phages
to hIgG or hIgG1-Fc more efficiently than SpA alone or
SpG alone (Fig. 5A, 5B, 5C, 5D). The conformation of Fc
was documented flexible, mobile and easy affected [26].
X-ray crystal structures studies for Fc and Fc-ligand com-
plex indicated that the hinge proximal region of CH2
domain is disordered, suggesting internal mobility, gener-
ating a dynamic equilibrium between multiple conform-
ers [27]. Interchange between heavy and light chain,
binding to antigen and change of primary amino acid
sequences of IgG (different IgG subtypes) would affect the
Fc conformation [28-30]. Although SpA shares a lot of
binding area in IgG-Fc with SpG, obvious difference
between these two interactions was observed [31,32].
First, in SpG: Fc and SpA: Fc complex, the two helices in
SpA domain are located mostly in CH2 side of Fc, the
helix of SpG lies wedged in the CH2-CH3 cleft. Second,
SpG interacts with Fc mainly through hydrogen bond,
while SpA through hydrophobic interaction. Third, Fc has
a set of unique amino acids for binding to SpG and SpA
respectively [26]. So, although the binding sites of SpA
and SpG overlap, their binding nature is different, and the
structure of PA(A)-PG could produce the different binding
avidity for a pair of Fc sites in one hIgG molecule from
that produced by PA(A/D)-PA (A/D) or PG-PG, which was
documented to possess some binding advantage, and
therefore showed the selection advantage.
In this work, the proportion of phage clones displaying
two and three domains also increased remarkably along
with the rounds of selection (Fig. 1, Fig. 2), and the link-
ing peptides were significantly selected (Table 2, Table 3).
These results might reflect the effectiveness of the selec-
tion and the significance of selected PA(A)-PG and PA(A)-
PL. The conformation of binding sites for IBPs of hIgA and
hIgM Fab were fixed and stable, as well as the linking pep-
tide among all selected PA(A)-PL structures showed some
convergent distribution. Different from the native hIgG,
the Fab of hIgG1-Fc was substituted by TNF receptor. It
Binding activities of seven fusion proteins of the novel combinatorial molecules, SpA, SpG and 4L with hIgG (A), hIgG1-Fc (B),  hIgM (C) and hIgA (D) respectively by Western Blot Figure 4
Binding activities of seven fusion proteins of the novel combinatorial molecules, SpA, SpG and 4L with hIgG 
(A), hIgG1-Fc (B), hIgM (C) and hIgA (D) respectively by Western Blot. Seven fusion proteins, SpA, SpG and 4L 
(each of 5 μg) were separated by electrophoresis in SDS-PAGE and electrotransferred to nitrocellulose membrane respec-
tively. The membrane was incubated with biotin labeled hIgG, hIgG1-Fc, hIgM and hIgA in 1:3 000 dilution respectively and 
detected with HRP-conjugated streptavidin, followed by developing with DAB. 1, fusion protein PA(A)3N-PG-PA(A); 2, fusion 
protein PA(A)6N-PG; 3, fusion protein PA(A)-PG; 4, fusion protein PA(A)-PG9N; 5, fusion protein PA(A)6N-PG3N; 6, fusion pro-
tein PA(A)9N-PL3N; 7, fusion protein PA(A)9N-PL; 8, fusion protein 4L; 9, SpA; 10, SpG.BMC Microbiology 2008, 8:137 http://www.biomedcentral.com/1471-2180/8/137
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Figure 5BMC Microbiology 2008, 8:137 http://www.biomedcentral.com/1471-2180/8/137
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could produce some conformation difference between
hIgG1-Fc and native hIgG, and could be responsible for
the divergent distribution of linking peptide in hIgG and
hIgG1-Fc post-selection populations. The phage binding
assay and competitive inhibition test also showed compa-
rable binding advantage for the clones from selection
hIgG population with hIgG, and for those from hIgG1-Fc
post-selection population with hIgG1-Fc (Fig. 3, Fig. 5C,
5D). This result suggested that the combinations and spe-
cial linkage of the different IBP domains could sensitively
reflect the conformational change in the binding sites of
Ig Fc.
Conclusion
In this study, a combinatorial phage library displaying
single domain randomly-rearranged molecules derived
from natural bacterial IBPs was selected with hIgG, hIgM,
hIgA and hIgG1-Fc. Two kinds of novel combinations of
Ig-binding domains, PA(A)-PG and PA(A)-PL, which
don't exist in natural bacterial Ig-binding molecules, were
obtained, and showed the comparable binding advan-
tages. It demonstrated the novel binding properties.
Methods
Single domain randomly-rearranged combinatorial phage 
displayed library
The construction of the phage library was described previ-
ously [33]. Briefly, gene fragments encoding A and D
domains of SpA [PA(A) and PA(D)], B2 domain of SpG
(PG) and B3 domain of protein L (PL) were individually
generated by PCR amplification using the primers (Table
4) which introduced recognition site for Xba I in both
ends of the fragments and nucleoside acid sequences in
the 3'-end, which encoding random linking peptide con-
sisted of 0, 1, 2 or 3 amino acids. Then the PCR products
were digested with Xba I and ligated into the Xba I site of
the phagemid pCANTAB5S to construct a phage displayed
random combinatorial library. The library has size of 2 ×
107 members, and titer of the phage library is calculated to
1.3 × 1011 transformation unit (TU)/ml. Host bacterial
strain TG1 was from Stratagene Company, Cambridge,
England. Primers located in the upward and downward of
the cloning site of vector pCANTAB5S were used to
amplify the inserted fragment of positive phages and to
perform sequencing analysis of inserted fragment. Both of
forward primer designated P1: 5'-CAA CGT GAA AAA ATT
ATT ATT CGC-3' and reverse primer designated P2: 5'-GTA
AAT GAA TTT TCT GTA TGA GG-3' was obtained from
Shanghai Sangon Biological Engineering Technology &
Services Co., Ltd.
Vectors and reagents
Phagemid vector pCANTAB5S and phage displaying E-D-
A-B-C domains of SpA (SpA-phage) were constructed by
our lab and has been described previously [34]. Briefly,
phagemid pCANTAB5S was obtained by inserting the
DNA fragment of Xba I-Stu I-Sal I-Kpn I-(Gly4Ser)3 into
pCANTAB5L (Pharmacia Biotech, Uppsala, Sweden)
between Sfi I and Not I cloning sites. The encoding
sequence of SpA [35] was inserted into pCANTAB5S at Stu
I site to construct SpA-phage. 2L-phage containing two
domains (B3-B3) of protein L was obtained from a phage
library displaying Ig-binding mono-domains of SpA and
protein L by affinity selection with hIgG [22]. Human IgG
(hIgG), human IgM (hIgM), human IgA (hIgA) and SpG
were from Sigma, St. Louis, MO, USA. Prokaryotic
expressed SpA (Genbank: P02976) and hIgG1-Fc mole-
cule that is obtained through substituting Fab of human
IgG1 with soluble receptor of human tumor necrosis fac-
tor (TNF) by gene engineering were kindly provided by
Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co. Ltd,
Shanghai, China. All antibodies were biotinylated using
biotinyl-N-hydroxy-succinimide (Pierce, Rockford, IL,
USA). Purified protein 4L containing four domains (B3-
B3-B3-B3) of protein L was expressed by using prokaryotic
expression vector pET32a(+) in E. coli BL21 following the
protocol provided by Novagen Company (Germany) and
purified by Ni-NTA column (Pharmacia Biotech) at our
lab (data not shown). Helper phage M13K07 and horse-
radish peroxidase (HRP)-conjugated anti-M13 antibody
were from Pharmacia Biotech, Uppsala, Sweden.
Competitive inhibition of PA(A)-PG-phages (A-D) and SpA-phage (E) binding to hIgG by PA(A)-PG combinations, PA(A)-PL  combinations, SpA, SpG and both SpA plus SpG Figure 5
Competitive inhibition of PA(A)-PG-phages (A-D) and SpA-phage (E) binding to hIgG by PA(A)-PG combina-
tions, PA(A)-PL combinations, SpA, SpG and both SpA plus SpG. 109TU of tested phages without and with each of 
100 nM (black bars) or 25 nM (white bars) of inhibitor proteins were added into hIgG-coated wells respectively. Unbound 
phages were removed and 10 μl of exponentially growing E. coli TG1 was added into each well, incubated for 1 h at 37°C. The 
TG1 cells were harvested respectively and spread LB plates containing 100 μg/ml ampicillin, and bacterial colonies were 
counted after incubating at 37°C overnight. Inhibition rate was calculated: [1 - (mean of the bacterial colonies from tested wells 
with inhibitor proteins - mean of the bacterial colonies from blank control wells) divided by (mean of the bacterial colonies 
from tested wells without inhibitor proteins - mean of the bacterial colonies from blank control wells)] × 100%. No. 1 to 6: 
The expressed fusion proteins of PA(A)3N-PG-PA(A), PA(A)6N-PG, PA(A)-PG9N, PA(A)6N-PG3N, PA(A)9N-PL3N and PA(A)9N-PL 
were used as inhibitors respectively. No. 7 to 9: SpA, SpG and that both were used as inhibitors respectively.BMC Microbiology 2008, 8:137 http://www.biomedcentral.com/1471-2180/8/137
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Selections of the phage displayed library with four Ig 
molecules
hIgG, hIgM, hIgA and hIgG1-Fc molecules were diluted in
coating buffer (0.1 M NaHCO3, pH 9.6) resulting in 10
μg/ml respectively and coated in sterile 96-well ELISA
plates at 37°C for 3 h. After blocking the plates with
blocking buffer (10% degreased milk powder, 0.1%
Tween 20 and 0.2% mercurothiolate in 0.01M phosphate-
buffered saline) for at least 1 h, phage displayed library
(about 1010–11 TU) was added into each well and incu-
Competitive inhibition of two representative PA(A)-PL-phages (A and B), SpA-phages (C) and 2L-phages (D) binding to hIgM  molecules by PA(A)-PL combinations, PA(A)-PG combinations, SpA, 4L and both SpA plus 4L Figure 6
Competitive inhibition of two representative PA(A)-PL-phages (A and B), SpA-phages (C) and 2L-phages (D) 
binding to hIgM molecules by PA(A)-PL combinations, PA(A)-PG combinations, SpA, 4L and both SpA plus 
4L. 109TU of PA(A)-PL-phages, 1011TU of SpA-phages and 1010TU of 2L-phages without and with each of 100 nM (black bars) 
or 25 nM (white bars) of inhibitor proteins were added into hIgM-coated wells respectively. Unbound phages were removed 
and 10 μl exponentially growing E. coli TG1 was added into each well, incubated for 1 h at 37°C. The TG1 cells were harvested 
respectively and spread LB plates containing 100 μg/ml ampicillin, and bacterial colonies were counted after incubating at 37°C 
overnight. Inhibition rate was calculated: [1 - (mean of the bacterial colonies from tested wells with inhibitor proteins - mean of 
the bacterial colonies from blank control wells) divided by (mean of the bacterial colonies from tested wells without inhibitor 
proteins - mean of the bacterial colonies from blank control wells)] × 100%. No. 1 to 6: The expressed fusion proteins of 
PA(A)3N-PG-PA(A), PA(A)6N-PG, PA(A)-PG9N, PA(A)6N-PG3N, PA(A)9N-PL3N and PA(A)9N-PL were used as inhibitors respec-
tively. No. 7 to 9: SpA, 4L and that both were used as inhibitors respectively.BMC Microbiology 2008, 8:137 http://www.biomedcentral.com/1471-2180/8/137
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bated for 3 h at 37°C. Unbound phages were removed by
washing with washing buffer (0.25% Tris, 0.05% Tween
20 in ddH2O) 30 times with vigorous pipetting, and 100
μl E. coli TG1 at an optical density at 600 nm of about 0.5
were added into wells, incubated for 1 h at 37°C. The
number of eluted phages was calculated by colony form-
ing units (c.f.u.) on TG1 cells in LB plates containing 100
μg/ml ampicillin. E. coli TG1 cells harboring eluted phage
were amplified for 1 h by shaking 250 rpm at 37°C in 8
ml LB medium. Then ampicillin (100 μg/ml) and helper
phages M13K07 (about 3 × 1012 TU) were added and the
E. coli TG1 cells were cultured as above. After 1 h, kanamy-
cin (50 μg/ml) was added and the E. coli TG1 cells were
grown continuously by shaking 180 rpm at 37°C over-
night. Phages were harvested by centrifugation (10 min,
5000 × g) of the medium and filtration of supernatant
through 0.22 μm filter membrane, then used for the sub-
sequent round of selection with the same bait. Three or
four rounds of selection were performed as above.
Detection of distribution and size of inserted fragments in 
primary library and each round post-selection population 
by PCR
Twenty two phage clones in primary library and each
round post-selection population were picked randomly
and cultured in 0.5 ml LB medium by shaking 250 rpm at
37°C for 5 h respectively. The culture medium was used
as template to amplify inserted fragments in these phages
by PCR. For DNA amplification, 1 μl of template was
added to a 50 μl reaction mixture containing 5 μl of 10×
reaction buffer (500 mM KCl, 100 mM Tris-HCl pH 9.0,
1% Triton X-100), 1 μmol of each primer (P1 and P2), 3
mmol Mg++, 100 μmol dNTP, 1 U Taq DNA polymerase (2
U/μl, Promega, Madison, WI, USA) and nuclease-free
water. The reaction mixture was amplified on a thermocy-
cler (Perkin Elmer Applied Biosystems, USA) for 30 cycles
of 30 s at 94°C, 30 s at 50°C, and 45 s at 72°C followed
by a 5 min extension at 72°C. PCR products were ana-
lyzed by electrophoresis in 1.2% agarose gel and detected
by staining with ethidium bromide. pCANTAB5S
phagemid and blank culture medium were used as tem-
plate for positive and negative controls respectively.
Sequence analyses
Five to eleven positive phage clones identified by PCR
were picked randomly from the primary phage library and
the third or fourth post-selection populations. Inserted
DNA fragment of positive phages were sequenced using
the primers P1 and P2. Corresponding amino acid
sequences were deduced from DNA sequences and a mul-
tiple sequence alignment was analyzed with the DNAS-
TAR software package.
Detection of representative positive phages binding to Ig 
molecules by ELISA
10  μg/ml each of Ig molecules (hIgG, hIgM, hIgA or
hIgG1-Fc) was coated on ELISA plate as described above.
About 2 × 1011  TU amplified representative positive
phages obtained from the each round of selection were
added to each well and then incubated for 2 h at 37°C.
The wells were washed with phosphate-buffered saline
(PBS) containing 0.05%Tween 20 and the bound phages
were detected with HRP-conjugated anti-M13 phage anti-
body. The development was performed by the addition of
Table 4: Primers for amplification of DNA fragments encoding each Ig-binding domains
Name Description Sequence(5' → 3')
PA(A)-Uxk Sense terminal primer of PA(A) C CTG GGT ACCTCT AGA* GCT GAC AAC AAC TTC AAC
PA(D)-Uxl Sense terminal primer of PA(D) TAT GGT ACC TCT AGA GCT GAC GCT CAG CAG AAC
PA(A/D)-Dxk Antisense random primer of PA(A/D) ACT GGT ACC TCT AGA (0N, 3N, 6N, 9N)** TTT CGG AGC CTG AGA TTC
PG-Uxk Sense terminal primer of PG GCG GGT ACC TCT AGA ACC TAC AAA CTG GTT ATC
PG-Dxk Antisense random primer of PG TCA GGT ACCTCT AGA (0N, 3N, 6N, 9N) TTC GGT AAC GGT GAA GGT
PL-Uxk Sense terminal primer of PL GCG GGT ACCTCT AGA AAA GAA AAA ACC CCG GAA
PL-Dxk Antisense random primer of PL TGC GGT ACC TCT AGA (0N, 3N, 6N, 9N) ACC AGC GAA TTT GAT GTT CAG
*: Italic and black parts represent Xba I recognition sites; **: Underlined parts represent the random linking sequence; 0N, 3N, 6N and 9N: the 
sequence of random linking peptides composed of non, three, six and nine nucleotides.
Table 5: Primers for amplifying exogenous DNA sequences of selected representative phages
Name Description Sequence (5' → 3')
5SNco-u Forward amplifying primer TATCCATGG*CTGCGGCCCAGCCGGCCTCT
5SNoG-d Reverse amplifying primer CCTGCGGCCGCAACTGCCGCCGCC
B-S-U Forward sequencing prime GGA TCC GAG CTC AGG CCT GTC GAC GGT ACC GTT
S-H-D Reverse sequencing primer GAG CTC AAG CTT ACC AGA TCC ACC ACC GCC GGT ACC
*: Underlined part represents Nco I recognition site.BMC Microbiology 2008, 8:137 http://www.biomedcentral.com/1471-2180/8/137
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diaminobenzidine (DAB) (Sigma, St. Louis, MO, USA),
and read at 490 nm in an ELISA Reader (Bio Rad). SpA-
phages and 2L-phages were used as positive controls
respectively. The pCANTAB5S-phage (obtained by infect-
ing E. coli TG1 with blank phagemid pCANTAB5S) was
used as a negative control.
Expression of the novel combinatorial molecules
Bacterial clones harboring positive phagemids displaying
five PA(A)-PG combinations and two PA(A)-PL combina-
tions were used as template respectively to amplify DNA
fragments by PCR using forward primer (5SNco-u) and
reverse primer (5SNoG-d). The forward primer 5SNco-u
contained Nco I recognition site (Table 5). The synthetic
primers were obtained from Shanghai Sangon Biological
Engineering Technology & Services Co., Ltd. For DNA
amplification, the composition in 50 μl reaction mixture
was the same as above. The reaction mixture was ampli-
fied on a thermocycler (Perkin Elmer Applied Biosystems,
USA) for 35 cycles of 30 s at 94°C, 30 s at 60°C, and 45 s
at 72°C followed by a 5 min extension at 72°C. The
amplified DNA fragment containing a BamH I cloning
site of the phagemid at 3' terminal of displayed sequence
was digested with Nco I and BamH I and inserted into the
Nco I-BamH I site of prokaryotic expression vector
pET32a(+) (Qiagen, Valencia, CA). The recombinant plas-
mid was identified and sequenced by forward sequencing
primer (B-S-U) and reverse sequencing primer (S-H-D)
(Table 5). Competent E. coli BL21(DE3) cells were trans-
formed using above positive recombinant plasmid medi-
ated by CaCl2 and spread on LB plates (containing 100 μg/
ml of Amp and 15 μg/ml of Kana), and cultured at 37°C
overnight. Transformed positive BL21(DE3) colony was
picked up and cultured in 500 ml LB medium by shaking
250 rpm at 37°C with ampicillin (100 μg/ml). The Log-
phase bacteria were induced expression by adding 500 μl
of 1 M isopropyl-beta-D-thiogalactopyranoside (IPTG) in
the medium and continuously cultured for 3 h. The pellet
cells were collected after centrifugation at 6 000 rpm for
10 min at 4°C and washed by PBS (pH 7.2). Then the cells
were resolved by using 8 M urea (pH 8.0) and Ni-NTA col-
umn (Amersham Pharmacia Biotech) was used to purify
the expression proteins. The purified proteins were dia-
lyzed thoroughly against PBS (pH 7.0). The concentra-
tions of the proteins were detected by routine Bradford
assay.
Competitive inhibition test
In order to avoid experimental results being interfered due
to binding of SpA-phage and other phages displaying
more than two IBP domains to conjugated secondary anti-
bodies, the competitive inhibition tests were established
in this study by using E. coli TG1 infection as a substitute
for HRP-conjugated anti-M13 phage antibody detection.
Briefly, 1 μg each of Ig molecules (hIgG, hIgG1-Fc, hIgA or
hIgM) were coated on sterile 96-well microtitration plates
by using 0.1 M NaHCO3 (pH 9.6) at 37°C for 3 h. After
blocking the plates with blocking buffer (10% degreased
milk powder, 0.1% Tween 20 and 0.2% mercurothiolate
in 0.01 M phosphate-buffered saline) for at least 1 h, the
tested phages without and with 100 nM or 25 nM of
inhibitor proteins were added into hIgG-coated or hIgG1-
Fc-coated wells respectively, and incubated at 37°C for 1
h. Unbound phages were removed by washing with wash-
ing buffer (0.25% Tris, 0.05% Tween 20 in ddH2O) 10
times with vigorous pipetting after incubating for 3 h at
37°C, and 10 μl E. coli TG1 at an optical density at 600 nm
of about 0.2 was added into each well, incubated for 1 h
at 37°C. The infected TG1 cells of each well were har-
vested respectively and spread LB plates containing 100
μg/ml ampicillin, and bacterial colonies were counted
after incubating at 37°C overnight. Three parallel wells of
each test were detected, and the mean of bacterial colonies
from each test wells was used to calculate the inhibition
rate. Inhibition rate wascalculated: [1 - (mean of the bac-
terial colonies from tested wells with inhibitor proteins -
mean of the bacterial colonies from blank control wells)
divided by (mean of the bacterial colonies from tested
wells without inhibitor proteins - mean of the bacterial
colonies from blank control wells)] × 100%.
Western Blot
Each of 5 μg of the tested combinatorial IBP molecules,
SpA, SpG and 4L were separated by electrophoresis in
sodium dodecyl sulphate-polyacrylamid gel electrophore-
sis (SDS-PAGE) and electrotransferred to nitrocellulose
membrane (Millipore, Pharmacia) respectively. The
membrane was blocked with blocking buffer (10%
degreased milk powder, 0.1% Tween 20 and 0.2% mer-
curothiolate in 0.01 M PBS) at 4°C over night. After wash-
ing with PBS containing 0.05% Tween 20, the membrane
was incubated with labeled hIgG (1 mg/ml, 1:3 000) at
37°C for 2 h. The membrane was washed with PBS con-
taining 0.05% Tween 20 for 6 times and detected with
HRP-conjugated streptavidin, followed by developing
with diaminobenzidine (DAB). The interactions of the
tested proteins with hIgG1-Fc, hIgM or hIgA were parallel
detected by Western Blot respectively as above.
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